Manzo Pharmaceuticals Inc (MNZO)
0.00
USD |
OTCM |
Apr 24, 16:00
Price Chart
Key Stats
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 99.99% |
Profile
Manzo Pharmaceuticals Inc formerly known as Fortune Oil & Gas Inc manufactures and sells products and owns patents in the field of supplemental and holistic cures sold through retail and online distribution. The company also develops its lactose intolerance product, in which it holds an exclusive patent license. Its primary products are dietary supplements, probiotics and natural remedies. In addition tit also owns other products, including a remedy for babies suffering from colic and/or digestive gas. Geographically, operation of the group is functioned through United States. |
URL | https://www.manzopharma.com |
Investor Relations URL | N/A |
HQ State/Province | Ontario |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | N/A |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Manzo Pharmaceuticals Inc formerly known as Fortune Oil & Gas Inc manufactures and sells products and owns patents in the field of supplemental and holistic cures sold through retail and online distribution. The company also develops its lactose intolerance product, in which it holds an exclusive patent license. Its primary products are dietary supplements, probiotics and natural remedies. In addition tit also owns other products, including a remedy for babies suffering from colic and/or digestive gas. Geographically, operation of the group is functioned through United States. |
URL | https://www.manzopharma.com |
Investor Relations URL | N/A |
HQ State/Province | Ontario |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | N/A |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |